These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9832967)

  • 1. Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-maze.
    Anseloni VZ; Brandão ML
    Behav Pharmacol; 1997 Nov; 8(6-7):533-40. PubMed ID: 9832967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and pharmacological validation of the elevated plus maze constructed with transparent walls.
    Anseloni VZ; Motta V; Lima G; Brandão ML
    Braz J Med Biol Res; 1995 May; 28(5):597-601. PubMed ID: 8555981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia.
    Albrechet-Souza L; Oliveira AR; De Luca MC; Tomazini FM; Santos NR; Brandão ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):571-9. PubMed ID: 15866360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethopharmacological analysis of rat behavior on the elevated plus-maze.
    Cruz AP; Frei F; Graeff FG
    Pharmacol Biochem Behav; 1994 Sep; 49(1):171-6. PubMed ID: 7816869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethopharmacological analysis of the open elevated plus-maze in mice.
    Sorregotti T; Mendes-Gomes J; Rico JL; Rodgers RJ; Nunes-de-Souza RL
    Behav Brain Res; 2013 Jun; 246():76-85. PubMed ID: 23470900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents.
    Jones N; Duxon MS; King SM
    Psychopharmacology (Berl); 2002 May; 161(3):314-23. PubMed ID: 12021835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat.
    Cruz-Morales SE; Santos NR; Brandão ML
    Pharmacol Biochem Behav; 2002 Jul; 72(4):973-8. PubMed ID: 12062588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial.
    Ramos A; Pereira E; Martins GC; Wehrmeister TD; Izídio GS
    Behav Brain Res; 2008 Nov; 193(2):277-88. PubMed ID: 18590774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze.
    Rodgers RJ; Cole JC; Aboualfa K; Stephenson LH
    Pharmacol Biochem Behav; 1995 Dec; 52(4):805-13. PubMed ID: 8587923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditioned increases in anxiogenic-like behavior following exposure to contextual stimuli associated with cocaine are mediated by corticotropin-releasing factor.
    DeVries AC; Pert A
    Psychopharmacology (Berl); 1998 Jun; 137(4):333-40. PubMed ID: 9676892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the rat exploratory behavior in the elevated plus-maze with Markov chains.
    Tejada J; Bosco GG; Morato S; Roque AC
    J Neurosci Methods; 2010 Nov; 193(2):288-95. PubMed ID: 20869398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat.
    Cole BJ; Hillmann M; Seidelmann D; Klewer M; Jones GH
    Psychopharmacology (Berl); 1995 Sep; 121(1):118-26. PubMed ID: 8539336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM; Canto-de-Souza A
    Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam.
    Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
    Psychopharmacology (Berl); 2002 Jan; 159(2):188-95. PubMed ID: 11862348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of midazolam and pentylenetetrazole on behavioral repetition and variation.
    Abreu-Rodrigues J; Hanna ES; de Mello Cruz AP; Matos R; Delabrida Z
    Behav Pharmacol; 2004 Dec; 15(8):535-43. PubMed ID: 15577452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA-coupled periaqueductal gray glycine receptors modulate anxioselective drug effects on plus-maze performance.
    De Souza MM; Schenberg LC; de Pádua Carobrez A
    Behav Brain Res; 1998 Feb; 90(2):157-65. PubMed ID: 9521547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
    Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The submerged plus maze as an assay for studying anxiety-like behaviour in fish.
    Hope BV; Hamilton TJ; Hurd PL
    MethodsX; 2019; 6():1832-1837. PubMed ID: 31497513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA-A receptor modulators alter emotionality and hippocampal theta rhythm in an animal model of long-lasting anxiety.
    Hoeller AA; Duzzioni M; Duarte FS; Leme LR; Costa AP; Santos EC; de Pieri CH; dos Santos AA; Naime AA; Farina M; de Lima TC
    Brain Res; 2013 Sep; 1532():21-31. PubMed ID: 23911836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in illumination, closed wall transparency and/or extramaze space influence both baseline anxiety and response to diazepam in the rat elevated plus-maze.
    Violle N; Balandras F; Le Roux Y; Desor D; Schroeder H
    Behav Brain Res; 2009 Oct; 203(1):35-42. PubMed ID: 19389429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.